G Sound Musik Video Of The Week

On the G! Mixtape Of The Month

On The G Archive

Thursday, June 27, 2013

Eminem Speaks On Near Death Experience In New Documentary "How To Make Money Selling Drugs"


                           Eminem Speaks On Near Death Experience In "How To Make Money Selling Drugs"
Eminem details his addiction to Vicodin, says his rock bottom could have resulted in death.
In the Matthew Cooke-directed documentary, How To Make Money Selling Drugs, noted Detroit emcee Eminem was in rare form as he spoke on his past addiction to the pain reliever Vicodin in a two-minute video clip from the film.
The Recovery rapper, who confessed to consuming close to 20 Vicodin, Ambien and Valium pills in the span of one day in a 2009 interview with Vibe magazine, touched on the moment he was first introduced to Vicodin and the mellowness that followed.
“When I took my first Vicodin, it was like this feeling of ‘ahh.’ Like everything was not only mellow, but didn’t feel any pain,” Eminem revealed. “It just kind of numbed things…I don’t know at what point exactly it started to be a problem. I just remember liking it more and more. People tried to tell me that I had a problem. I would say, ‘Get that fuckin person outta here. I can’t believe they said that shit to me.’ They knew nothing about my fuckin life. Are they out of their fuckin mind? I’m not out there shooting heroine. I’m not fucking out there putting coke up my nose. I’m not smoking crack.”
Eminem’s addiction to the drug took a turn for the worse when the rapper found himself in the hospital, an experience he also detailed in Cooke’s documentary.
“Had I have got to the hospital about two hours later, I would have died. My organs were shutting down. My liver, kidneys, everything. They were gonna have to put me on dialysis. They didn’t think I was gonna make it. My bottom was gonna be death,” said the rapper.
How To Make Money Selling Drugs was released in the United States on April 25 and includes appearances from 50 Cent, Russell Simmons, Freeway Ricky Ross, and more.
 

No comments:

Post a Comment